Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7020071
Reference Type
Journal Article
Subtype
Review
Title
Applications for Transition-Metal Chemistry in Contrast-Enhanced Magnetic Resonance Imaging
Author(s)
Gupta, A; Caravan, P; Price, WS; Platas-Iglesias, C; Gale, EM; ,
Year
2020
Is Peer Reviewed?
Yes
Journal
Inorganic Chemistry
ISSN:
0020-1669
EISSN:
1520-510X
Publisher
AMER CHEMICAL SOC
Location
WASHINGTON
Volume
59
Issue
10
Page Numbers
6648-6678
Language
English
PMID
32367714
DOI
10.1021/acs.inorgchem.0c00510
Web of Science Id
WOS:000535304900002
Abstract
Contrast-enhanced magnetic resonance imaging (MRI) is an indispensable tool for diagnostic medicine. However, safety concerns related to gadolinium in commercial MRI contrast agents have emerged in recent years. For patients suffering from severe renal impairment, there is an important unmet medical need to perform contrast-enhanced MRI without gadolinium. There are also concerns over the long-term effects of retained gadolinium within the general patient population. Demand for gadolinium-free MRI contrast agents is driving a new wave of inorganic chemistry innovation as researchers explore paramagnetic transition-metal complexes as potential alternatives. Furthermore, advances in personalized care making use of molecular-level information have motivated inorganic chemists to develop MRI contrast agents that can detect pathologic changes at the molecular level. Recent studies have highlighted how reaction-based modulation of transition- metal paramagnetism offers a highly effective mechanism to achieve MRI contrast enhancement that is specific to biochemical processes. This Viewpoint highlights how recent advances in transition-metal chemistry are leading the way for a new generation of MRI contrast agents.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity